Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types

Autor: del Rio-Moreno, Mercedes, Alors-Perez, Emilia, Borges de Souza, Patricia, Prados-Gonzalez, Maria E., CastaÑo, Justo P., Luque, Raul M., Gahete, Manuel D.
Zdroj: In Translational Research September 2019 211:147-160
Databáze: ScienceDirect